A biomarker reflecting expression levels of two genes in tumor tissue may be able to predict which women treated for estrogen-receptor-positive breast cancer should receive a second estrogen-blocking medication after completing tamoxifen treatment.
Fuente : http://feeds.sciencedaily.com/~r/sciencedaily/~3/k...
Fuente : http://feeds.sciencedaily.com/~r/sciencedaily/~3/k...